Hospital Universitario de Cruces-ko ikertzaileekin lankidetzan egindako argitalpenak (116)

2024

  1. Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease

    npj Parkinson's Disease, Vol. 10, Núm. 1

  2. Implication of nutrition in severity of symptoms and treatments in quality of life in Parkinson’s disease: a systematic review

    Frontiers in Nutrition, Vol. 11

  3. Machine Learning for Prediction of Cognitive Deterioration in Patients with Early Parkinson’s Disease

    Applied Sciences (Switzerland), Vol. 14, Núm. 18

  4. Plasma Neurofilament Light Chain: A Potential Biomarker for Neurological Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    Biomedicines, Vol. 12, Núm. 7

  5. Predicting Parkinson’s Disease Progression: Analyzing Prodromal Stages Through Machine Learning

    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

  6. Prognostic factors for falls in Parkinson’s disease: a systematic review

    Acta Neurologica Belgica, Vol. 124, Núm. 2, pp. 395-406

  7. Understanding the olfactory role in post-COVID cognitive and neuropsychiatric manifestations

    Frontiers in Psychology, Vol. 15

2023

  1. Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study

    Biomedicines, Vol. 11, Núm. 2

  2. Correction to: Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease (Journal of Neurology, (2023), 270, 1, (519-529), 10.1007/s00415-022-11427-x)

    Journal of Neurology

  3. Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies

    Neural Computing and Applications, Vol. 35, Núm. 8, pp. 5603-5617

  4. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome

    Journal of Translational Medicine, Vol. 21, Núm. 1

  5. Multiple system atrophy: Clinical, evolutive and histopathological characteristics of a series of cases

    Neurologia, Vol. 38, Núm. 9, pp. 609-616

  6. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease

    Journal of Neurology, Vol. 270, Núm. 8, pp. 3821-3829

  7. SYNAPSES. Estudio observacional europeo para evaluar la seguridad y la efectividad de la safinamida en la práctica clínica habitual: análisis post hoc de la población española del estudio

    Revista de neurologia, Vol. 77, Núm. s02, pp. 1-12

  8. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

  9. Usefulness of thermography in the diagnosis and classification of complex regional pain syndrome

    Neurologia, Vol. 38, Núm. 5, pp. 342-349

  10. Virtual coach and telerehabilitation for Parkinson´s disease patients: vCare system

    Journal of Public Health (Germany)

2022

  1. Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?

    Journal of Translational Medicine, Vol. 20, Núm. 1

  2. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 96, pp. 29-35

  3. Costs and effects of telerehabilitation in neurological and cardiological diseases: A systematic review

    Frontiers in Medicine, Vol. 9